pulmonary foreign body granulomatosis
Jump to navigation
Jump to search
Etiology
- injection or nasal inhalation of pulverized tablets, often opioids or stimulants, that contain inert fillers such as crospovidone, talc, or cellulose
Pathology
- perivascular aggregates of histiocytes & foreign-body giant cells with abundant basophilic foreign material in coral-like structures (histopathology)[1]
- mucicarmine staining
Diagnostic procedures
- lung-biopsy sample obtained by video-assisted thoracoscopic wedge resection (case report)[1]
Radiology
- CT of chest (image)[1]
- diffuse, centrilobular nodules in both lungs
Management
- treatment of the underlying substance abuse disorder
More general terms
References
- ↑ 1.0 1.1 1.2 1.3 Staloch DA, Hedley JS Pulmonary Foreign-Body Granulomatosis. N Engl J Med 2017; 377:1273. September 28, 2017 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/28953434 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMicm1701787